Revenue Performance - For the three months ended January 31, 2026, total revenues increased by 121.89% to $1,383,941 compared to $623,709 for the same period in 2025[168]. - The company generated $1,000,000 from sales of recyclable e-waste materials, which accounted for 72.26% of total revenues for the quarter[168]. - Revenues for the three months ended January 31, 2026, were $1,383,941, an increase of $760,232 or 121.89% compared to $623,709 for the same period in 2025, primarily driven by increased sales of recyclable e-waste materials[179]. - Revenue from sales of recyclable materials accounted for 68.08% of total revenues for the nine months ended January 31, 2026, with an increase of $1,000,000 from nil in 2025[197]. - Revenues for the nine months ended January 31, 2026, were $1,468,941, an increase of $708,358 or 93.13% compared to $760,583 for the same period in 2025[204]. - The increase in revenues was primarily attributed to increased sales of recyclable e-waste materials by $1,000,000, partially offset by decreased sales in food imports and consulting services[204]. Cost and Expenses - Total cost of revenues increased by 243.01% to $1,300,286 for the three months ended January 31, 2026, compared to $379,081 in 2025[174]. - Cost of revenues for the three months ended January 31, 2026, was $1,300,286, a significant increase of $921,205 or 243.01% from $379,081 in 2025, mainly due to the new operating segment of recyclable e-waste materials[182]. - General and administrative expenses rose to $635,248 for the three months ended January 31, 2026, an increase of $500,425 or 371.17% from $134,823 in 2025, largely due to higher professional fees and increased insurance expenses[187]. - Selling expenses surged to $1,314,182, an increase of $1,227,844 or 1,422.14% from $86,338 in 2025, primarily due to increased advertising and marketing expenses[211]. - General and administrative expenses rose to $2,388,059, reflecting an increase of $1,445,485 or 153.36% compared to $942,574 in 2025, driven by higher professional fees and rent expenses[212]. Profitability - Gross profit for the three months ended January 31, 2026, was $83,655, a decrease of $160,973 or 65.80% compared to $244,628 in 2025, with a gross margin of 6.04% versus 39.22% in the prior year[185]. - The gross profit margin for the sale of food and beverage dropped to 5.02% in 2026 from 40.37% in 2025, indicating significant challenges in this segment[185]. - Gross profit decreased to $168,603 for the nine months ended January 31, 2026, a decline of $163,618 or 49.25% from $332,221 in 2025, with a gross margin of 11.48% compared to 43.68% in 2025[210]. Net Loss - Net loss from continuing operations for the three months ended January 31, 2026, was $548,336, compared to a net income of $80,226 in 2025, representing an increase in net loss of $628,562 or 783.49%[190]. - Net loss from continuing operations was $3,517,720 for the nine months ended January 31, 2026, compared to a loss of $703,642 in 2025, representing an increase of $2,814,078 or 399.93%[215]. - Net loss for the nine months ended January 31, 2026, was $4,164,376, an increase of $3,744,894 or 892.74% from a loss of $419,482 in 2025[217]. Cash Flow and Liquidity - The company had a cash balance of approximately $0.30 million and accounts receivable of approximately $0.22 million as of January 31, 2026[219]. - The company reported a net loss from continuing operations of approximately $3.52 million for the nine months ended January 31, 2026, and a cash outflow from operating activities of approximately $1.30 million during the same period[221]. - Net cash used in operating activities from continuing operations increased by $254,275 compared to the same period in 2025, primarily due to an increased net loss and higher outstanding accounts receivable[225]. - Net cash used in investing activities from continuing operations was $880,000 for the nine months ended January 31, 2026, compared to nil for the same period in 2025, mainly due to loans made to Bio Essence Pharmaceutical and Valemi Inc.[227]. - Net cash provided by financing activities from continuing operations was $1,607,213 for the nine months ended January 31, 2026, compared to a net cash outflow of $14,289 for the same period in 2025[229]. - As of January 31, 2026, the company's working capital was approximately $2.15 million, with plans to improve liquidity through operational cash flows, debt financing, and potential equity financing[220]. Market Strategy - The company has temporarily paused certain imports from China and is pursuing alternative sourcing strategies to mitigate risks associated with trade policies[158]. - The company is actively working with Costco and other retailers to introduce new products that are less sensitive to tariff tensions between the U.S. and China[158]. - The company plans to diversify its markets from major mass market channels to ethnic supermarket chains to increase revenue[170]. - The company plans to diversify its markets from major mass market channels to ethnic supermarket chains to increase revenue from its FuAn brand[221]. - The company is actively developing relationships with potential customers in the United States for its recyclable e-waste materials sales[242]. Regulatory and Accounting Matters - The Company follows FASB ASC Topic 740 for tax position recognition and measurement, which includes evaluating the likelihood of sustaining a tax position on audit[245]. - The Company utilizes a two-step approach for uncertain income tax positions, measuring tax benefits based on a more than 50% likelihood of realization[246]. - The Company is evaluating the impact of ASU 2024-03, which requires detailed disclosures about expenses, effective for annual reporting periods beginning after December 15, 2026[249]. - ASU 2025-01, issued in January 2025, addresses expense disaggregation disclosures, effective for annual reporting periods beginning after December 15, 2026[250]. - The Company does not expect the adoption of ASU 2025-03 regarding business combinations to materially impact its financial position or results of operations[252]. - The Company is currently evaluating the impact of ASU 2025-04 on stock compensation and revenue recognition, effective for annual reporting periods beginning after December 15, 2026[253]. - The Company is assessing the implications of ASU 2025-05 on credit loss measurement for accounts receivable, effective for annual reporting periods beginning after December 15, 2025[254]. - Management believes that no other recently issued guidance will materially impact the Company's financial statement presentation or disclosures[255]. - The Company is classified as a smaller reporting company and is not required to provide certain market risk disclosures[257]. Concerns and Risks - The company has a substantial doubt about its ability to continue as a going concern for the next 12 months due to potential cash resource needs for investments or acquisitions[222].
Marwynn Holdings Inc(MWYN) - 2026 Q3 - Quarterly Report